Literature DB >> 25317074

A novel PCR-based approach to discover miRNA target genes.

Shiwei Duan1, Yunliang Wang2, Hongwei Wang3, Shufei Wang4, Lindan Ji1, Dongjun Dai1, Danjie Jiang1, Xiaoxi Zhang2, Qiang Wang5.   

Abstract

MiRNAs are potent regulators of gene expression, and most miRNAs have from several to several thousands of gene targets. Validating the numerous gene targets of a given miRNA remains challenging despite the existence of various tools and databases that predict candidate gene-miRNA pairs. In the present study, we present a high-throughput but flexible method that applies a PCR-based application to simulate the binding of miRNAs to their gene targets. Using hsa-miR-377 as an illustrative example, our method was able to identify 13 potential targets of hsa-miR-377. Moreover, our results include 2 genes (SOD2 and PPM1A) that have already been verified as targets of hsa-miR-377. Our method may provide an alternative way of identifying the gene targets of miRNAs for future research.

Entities:  

Keywords:  gene target; high-throughput.; hsa-miR-377; miRNA

Mesh:

Substances:

Year:  2014        PMID: 25317074      PMCID: PMC4196129          DOI: 10.7150/ijms.9343

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


Introduction

Mature miRNAs are a class of small single-stranded RNAs roughly 20 nts long. They are potent regulators of gene expression and are predicted to modulate the expression of several to several thousands of genes. MiRNAs act through pair-matching of their seed sequence to the 3'-untranslated regions of gene transcripts 1. Identifying the gene targets of miRNAs is crucial for illustrating the biological mechanisms underlying these powerful regulatory molecules. Elucidating the role of miRNA regulation on gene expression has contributed to the mechanistic understanding of cardiogenesis 2, skeletal muscle proliferation and differentiation 3, drug resistance 4, and cancer metastasis 5. Dysfunction of miRNA-gene targeting may lead to many diseases such as cancer 5, complex psychiatric disorder 6, and addiction 7. While a number of computational algorithms have been published to predict the target genes of a given miRNA, huge discrepancies exist in the predicted results of these algorithms 8. Although there are curated databases on miRNA-gene targeting relationships 9 (http://diana.cslab.ece.ntua.gr/tarbase/), the validation of these various bioinformatic predictions remains a challenge for researchers. In the present studies, we propose a novel PCR-based chip assay that can be used to supplement the existing approaches. It is based on the seed-match theory between miRNA sequences and the 3'-UTR of their target mRNAs 10, 11. Coupled with gene expression microarray, this PCR-based in-vitro approach can be used to quantify the binding ability of miRNAs to target mRNAs.

Methods and materials

First-strand cDNA synthesis and the 3'-UTR amplification of miR-377 target genes

The total RNAs of normal human mesangial cells were extracted with TRIZOL (Invitrogen Corporation, Carlsbad, CA, USA). Details of cell culture are as described previously 12. As shown in Figure 1, total RNA was reversely transcribed to cDNA using a P-oligo-dT primer with a 5'-overhanged sequence (5'-GGCTAGTCTCGTGATCGA-3'). Then the cDNA mixture was used for PCR amplication using a tag primer (5'-GGCTAGTCTCGTGATCGA-3') and hsa-miR-377 derived primer (5'-ACAAAAGTTGCCTTTGTGTT-3'; the ““ stands for a lock nucleotide acid) or its control primer with 3 mutations (, and ) in the underlined region complemented to hsa-miR-377 (5'-ACAAATGTAGCGTTT-3'). PCR was performed as follows: 3 min at 95ºC followed by 5 cycles of amplification (30 sec at 95ºC, 30 sec at 45ºC, 2 min at 72 ºC), and another 30 cycles (30 sec at 95ºC, 30 sec at 54ºC, 2 min at 72 ºC) for further amplification.
Figure 1

The workflow of the PCR-based approach to identify miRNA target genes.

Quantification of the amplified 3'-UTRs in cDNA pools and identification of target genes of miR-377

PCR products were labeled (Bioprimer DNA labeling System, Invitrogen) and hybridized with human expression microarrays (GeneChip Human Gene 1.0 ST Array; Affymetrix, Santa Clara, CA, USA). The image data were analyzed by DNA-Chip Analyzer (http://www.dchip.org) to generate a normalized signal for each gene's exon on the array. The potential target genes of hsa-miR-377 met the following criteria. Firstly they must have probes in 3'-UTRs with a signal intensity of at least 1000. Secondly, they need to have probes in other regions (coding sequences (CDS) or 5'-UTR) with a signal intensity of less than 200. Finally, the ratio of the signal intensity of 3'-UTRs between miR-377 derived primer PCR input and its control PCR input has to be greater than 10 for these miR-377 target genes. In the current microarray, the signal intensity of 200 suggests a moderate amount of capturing the PCR products using the primer sets. For the same gene, a >1000 value in the 3-UTR and <200 value in other gene regions suggests an enrichment of 3'-UTR targeting in the seed-containing primer set, implying a potential targeting between miR-377 seed sequence and the identified gene.

Results

In the present study, we are able to identify 13 genes, as listed in Table 1 and Figure 2. Eight of them (over 60%) are also predicted to miR-377 targets 11, 13-16. Other genes with less stringent criteria are shown in the Supplementary Material: Table S1. A list of 16,319 transcripts were harvested by sorting the ratio of the 3'-UTR probe signal intensity between miR-377 derived primer PCR input and miR-377 mutated primer PCR input (Supplementary Material: Table S2). The fasta sequences of the 3'-UTRs of transcripts are retrieved from the ENSEMBL website (http://www.ensembl.org/index.html). By using the 8-letter enrichment analysis of Sylmer, we find that “TTGTGTGA” as the seed of miR-377 is significantly enriched in the UTRs of the top transcripts (Figure 1).
Table 1

The target genes of hsa-miR-377 a.

GeneEntrez idRatioTarget predictions
ZRANB29406305.73
PITPNA5306161.58
GCH12643137.16PITA
CSE1L1434123.82
PPM1A5494104.08miRanda, PITA
VTA15153498.83TargetScan_nonconserved
KITLG425496.78TargetScan_nonconserved, PITA
CLASP22312287.43miRanda, TargetScan_nonconserved, PITA
SON665164.23miRanda, TargetScan_nonconserved, PITA
RPP301055659.19TargetScan_nonconserved, PITA
CLEC2D2912142.76
EIF5B966931.75miRanda, TargetScan_conserved, PITA
KLF6131623.07

a: Ratio is the ratio of the 3'-UTR probe signal intensity between miR-377 derived primer PCR input and miR-377 mutated primer PCR input.

Figure 2

Over-representative 3'-UTRs of the hsa-miR-377 target genes in the PCR.

As shown in Figure 1, our method comprises of a first strand cDNA synthesis of the transcriptome and a subsequent PCR to amplify the 3'-UTR regions using the miRNA-complement primers. The background noise is controlled by the PCR of another primer with a seed-mutated miRNA sequence coupled with the tag primer. After the PCR procedure, the products are labeled and hybridized onto gene expression array. The levels of the signal-to-noise ratios of the probes in the 3'-UTRs of genes reflect their binding capability to miRNAs. Using hsa-miR-377 as an example, we coupled the tag primer with the primer complementary to the sequence of hsa-miR-377. In addition, the control PCR uses the tag primer and a primer with mismatches in the seed region of hsa-miR-377. By ranking the signal-to-noise ratio of amplified genes, we find that there is a significant enrichment of miR-377 seed (TTGTGTGA) in the 3'-UTR of the ranked mRNAs using the Sylamer software 17. Additionally, 8 of the aforementioned 13 genes were previously predicted to be miR-377 targets by various in-silico methods (Table 1 and Supplementary Material: Table S1). SOD2 (Supplementary Material: Table S2) and PPM1A (Table 1) have already been validated as targets of miR-377 in the previous studies 12.

Discussions

Using hsa-miR-377 as an example, we found 13 genes that potential interact with hsa-miR-377, a miRNA associated with diabetes nephropathy 12 and cancer progression 18. Among the identified target genes of hsa-miR-377, at least three [GCH1 19, PPM1A 20-22 and KLF6 23, 24] were shown to be linked to the pathogenesis of diabetes and five [GCH1 25, 26, CSE1L 27, PPM1A 28, KITLG 29 and KLF6 30] were shown to be linked to the pathogenesis of cancer. These potential targets of hsa-miR-377 are likely to provide hints for future research on the contribution of hsa-miR-377 in diabetes and cancers. The classic method for validating the gene targets of a miRNA is the luciferase reporter assay 31, which is designed to test whether or not there is a reduction in luciferase enzyme activity through the miRNA binding to the foreign sequence in the 5'-flanking region of the luciferase gene. Although this method is accurate and thus has become the standard method, it is also labor-intensive and low-throughput. Other high-throughput methods include the anti-miRNA knock down assay 32 and the immunoprecipitation-based chip (ChIP-chip) or sequencing assays (ChIP-Seq) 33. While the anti-miRNA knock down assay can generate a list of associated genes, it is hard to distinguish between the primary gene targets and other genes that are subsequently influenced by non-miRNA factors. The most recent Argonaute immunoprecipitation-based chip or sequencing arrays have become a very successful approach that can capture the miRNA and its gene targets simultaneously. However, it seems that only the most abundant miRNAs are suitable for this approach. Our method simulates in vivo binding between a miRNA and its targets. And it can be easily expanded to discover the differences in the gene regulation among the genome-wide miRNAs by comparing the PCR signals from different miRNA primer sets. This method can potentially be used to identify novel miRNA binding targets by employing next generation sequencing techniques to sequence the PCR products. However, there are some limitations to this system. For examples, the oligo-dT primer can't pick up genes lacking 3'-UTR sequences. And for some mature miRNAs with length fewer than 18 bps, this method may fail to design eligible primers due to the severe nonspecific PCR amplification events. In summary, our study uses a PCR-based approach to simulate the binding between miRNA and the 3'-UTRs of their target genes. This technique is able to reveal novel target genes of a given miRNA in a high-throughput manner. Using human miR-377 as an example, our study shows that the top ranked target genes are significantly enriched with miR-377 seed matched regions in their 3'-UTRs. This approach may provide an alternative way of revealing the targets of miRNAs for future research. Table S1: The list of genes with significant enrichment of the hsa-miR-377 seed-matched sequence in the 3'-UTRs. Table S2: The gene list for Sylmer program. Click here for additional data file.
  33 in total

1.  The role of site accessibility in microRNA target recognition.

Authors:  Michael Kertesz; Nicola Iovino; Ulrich Unnerstall; Ulrike Gaul; Eran Segal
Journal:  Nat Genet       Date:  2007-09-23       Impact factor: 38.330

Review 2.  Analysis of microRNA effector functions in vitro.

Authors:  Bingbing Wang; John G Doench; Carl D Novina
Journal:  Methods       Date:  2007-10       Impact factor: 3.608

3.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

Review 4.  Termination of TGF-beta superfamily signaling through SMAD dephosphorylation--a functional genomic view.

Authors:  Xia Lin; Yeguang Chen; Anming Meng; Xinhua Feng
Journal:  J Genet Genomics       Date:  2007-01       Impact factor: 4.275

Review 5.  Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.

Authors:  Verónica Andreoli; Ricardo C Gehrau; Jose Luis Bocco
Journal:  IUBMB Life       Date:  2010-12       Impact factor: 3.885

6.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

7.  MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Authors:  Qiang Wang; Youli Wang; Andrew W Minto; Jinhua Wang; Qun Shi; Xinmin Li; Richard J Quigg
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

Review 8.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

9.  Detecting microRNA binding and siRNA off-target effects from expression data.

Authors:  Stijn van Dongen; Cei Abreu-Goodger; Anton J Enright
Journal:  Nat Methods       Date:  2008-11-02       Impact factor: 28.547

10.  Transcript-specific expression profiles derived from sequence-based analysis of standard microarrays.

Authors:  Anton G Moll; Maja T Lindenmeyer; Matthias Kretzler; Peter J Nelson; Ralf Zimmer; Clemens D Cohen
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

View more
  1 in total

1.  miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.

Authors:  Jianan Yang; Daozhang Yuan; Jing Li; Shunsheng Zheng; Bin Wang
Journal:  Tumour Biol       Date:  2015-10-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.